Biocept Inc. Capital Reinvestment Ratio

Latest as of December 2021: 0.43x

Biocept Inc. capital reinvestment ratio. Biocept Inc. (BIOCQ) has a Capital Reinvestment Ratio of 0.43x as of December 2021, meaning it reinvests 0% of its operating cash flow ($3.69 Million) in capital expenditures ($1.57 Million). Check Biocept Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.43x
Capex / Operating Cash Flow

Operating Cash Flow

$3.69 Million
USD

Capital Expenditures

$1.57 Million
USD

Data as of

Dec 2021
Most recent filing

Capital Reinvestment Ratio of Biocept Inc. (2021–2021)

Capital reinvestment ratio of Biocept Inc. from 2021 to 2021. This chart tracks Biocept Inc.'s Capital Reinvestment Ratio across 1 annual periods. Also explore BIOCQ year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Biocept Inc. Capital Reinvestment Ratio by Year (2021–2021)

Biocept Inc. capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see Biocept Inc. cash flow conversion.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2021 0.43x $3.69 Million $1.57 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow